Results 181 to 190 of about 38,942 (318)

PSS12 COST-EFFECTIVENESS ANALYSIS OF BEVACIZUMAB AND RANIBIZUMAB IN NEOVASCULARAGE-RELATED MACULAR DEGENERATION (AMD): A CLINICAL AND ECONOMIC COMPARISON OF TWO VASCULAR ENDOTHELIAL GROWTH FACTOR INHIBITOR TREATMENTS

, 2008
JJ Patel, MA Stull, Mark Bounthavong, MLD Christopher, E. Johan Foster, AP Morreale, BK Plowman, DT Boggie   +7 more
openalex   +1 more source

Treatment of a choroidal neovascular membrane in a patient with late-onset retinal degeneration (L-ORD) with intravitreal Ranibizumab [PDF]

, 2010
Kyaw Aye, Rohit Kumar Gupta, James Talks, Andrew C. Browning   +3 more
openalex   +1 more source

Persistent Macular Thickening Following Intravitreous Aflibercept, Bevacizumab, or Ranibizumab for Central-Involved Diabetic Macular Edema With Vision Impairment: A Secondary Analysis of a Randomized Clinical Trial

JAMA ophthalmology, 2018
N. Bressler, Wesley T Beaulieu, A. Glassman, K. Blinder, S. Bressler, L. Jampol, M. Melia, J. Wells   +7 more
semanticscholar   +1 more source

Computational Fluid Dynamics Modeling of Intravitreal Ranibizumab Bolus Versus Subretinal ABBV-RGX-314 Transgene Product in Human Eyes. [PDF]

Transl Vis Sci Technol
Park J, Kazemi M, Tamhane M, Shen J.
europepmc   +1 more source

Ranibizumab for retinal angiomatous proliferation in age-related macular degeneration [PDF]

, 2010
K. Atmani, M. Voigt, V. Le Tien, Giuseppe Querques, G. Coscas, G. Soubrane, Eric H. Souied   +6 more
openalex   +1 more source

Biosimilar Versus Innovator Ranibizumab in Myopic CNVM: Comparative Real-World Outcomes- The BRIM Study

Clinical Ophthalmology
Debdulal Chakraborty,1 Tushar Kanti Sinha,1 Sourav Sinha,2 Rupak Kanti Biswas,2 Aniruddha Maiti,3 Krishnendu Nandi,2 Dinesh Rungta,1 Ranabir Bhattacharya1 1Vitreo-Retina Services, Disha Eye Hospitals, Kolkata, WB, India; 2Vitreo-retina Services ...
Chakraborty D, Sinha TK, Sinha S, Biswas RK, Maiti A, Nandi K, Rungta D, Bhattacharya R   +7 more
doaj  

Visual acuity outcomes in ranibizumab-treated neovascular age-related macular degeneration; stratified by baseline vision [PDF]

, 2010
O. Shona, Bhaskar Gupta, Roopa Vemala, Sobha Sivaprasad   +3 more
openalex   +1 more source

Efficacy and safety of intravitreal anti-VEGF for myopic choroidal neovascularization. [PDF]

Int J Ophthalmol
Liu JY, Liu JP, Li XR.
europepmc   +1 more source

Intravitreal ranibizumab treatment of retinal angiomatous proliferation [PDF]

, 2010
Christina Kramann, Kilian Schöpfer, Katrin Lorenz, Isabella Zwiener, Bernhard Stoffelns, Norbert Pfeiffer   +5 more
openalex   +1 more source

Model-based pharmacoeconomic analysis of anti-VEGF strategies for neovascular age-related macular degeneration: a value-based comparison of real-world administration approaches. [PDF]

BMJ Open
Gismero Moreno SM, Jódar Sánchez F, García-Agua Soler N, Rivas Ruiz F, Garcia-Ruiz AJ.   +4 more
europepmc   +1 more source